TY - JOUR
T1 - The effect of different organic solvents in liposome properties produced in a periodic disturbance mixer
T2 - Transcutol®, a potential organic solvent replacement
AU - López, Rubén R.
AU - G. Font de Rubinat, Paula
AU - Sánchez, Luz María
AU - Tsering, Thupten
AU - Alazzam, Anas
AU - Bergeron, Karl F.
AU - Mounier, Catherine
AU - Burnier, Julia V.
AU - Stiharu, Ion
AU - Nerguizian, Vahé
N1 - Funding Information:
This work was supported by the grant CONACyT-ETS [389081] , Concordia University, NSERC [REN253] , École de technologie supérieure, Khalifa University [CIRA-2019-014] and UQAM, NSERC [RGPIN-2019-06738] .
Funding Information:
This work was supported by the grant CONACyT-ETS [389081], Concordia University, NSERC [REN253], ?cole de technologie sup?rieure, Khalifa University [CIRA-2019-014] and UQAM, NSERC [RGPIN-2019-06738]. We would like to thank CMC Microsystems that supported this work through equipment lending and Gattefoss? Canada Inc which provided HP Transcutol?. The authors wish to thank Ixchel Ocampo from the Tecnol?gico de Monterrey, for the advice on micromixer fabrication as well as Prasun Lala from ?TS SARA group who provided with writing assistance. Finally, we would like to acknowledge the chemical department at UQAM, and the NANOQAM network for the training in nanoparticle characterization, and equipment use. Especially to Galyna Shul, Jacqueline Hue Tieu, and Luc Arsenault.
Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2021/2
Y1 - 2021/2
N2 - Liposomes are versatile particles used in the biomedical field as drug delivery systems (DDS). Liposome production using micromixers have shown to yield nanoparticles for DDS in a single step with a controllable size by changing flow conditions. Nonetheless, other factors such as the organic solvent, play a crucial role in the liposome formation process. Furthermore, drug solubility and toxicity are pivotal when deciding which organic solvent to choose. In this work, liposomes were produced in a periodic disturbance mixer (PDM). We investigated three conventional organic solvents: ethanol, methanol, and isopropanol as well as Transcutol®. We assessed the organic solvent influence on liposome characteristics (size, size distribution and zeta potential). Among the four organic solvents, Transcutol® yielded the smallest liposomes, which ranged from 80 nm to 160 nm. Moreover, a more in-depth investigation showed that Transcutol® produced smaller or similar-sized particles under different temperature and lipid concentration conditions, compared with ethanol. Furthermore, we proved that particles zeta potential was not influenced by the organic solvent, production temperature, or lipid concentration. This work results show that Transcutol® could replace the conventional alcohol-based solvents and can potentially avoid filtration steps due to its low toxicity. Therefore, the present approach is appealing for DDS development.
AB - Liposomes are versatile particles used in the biomedical field as drug delivery systems (DDS). Liposome production using micromixers have shown to yield nanoparticles for DDS in a single step with a controllable size by changing flow conditions. Nonetheless, other factors such as the organic solvent, play a crucial role in the liposome formation process. Furthermore, drug solubility and toxicity are pivotal when deciding which organic solvent to choose. In this work, liposomes were produced in a periodic disturbance mixer (PDM). We investigated three conventional organic solvents: ethanol, methanol, and isopropanol as well as Transcutol®. We assessed the organic solvent influence on liposome characteristics (size, size distribution and zeta potential). Among the four organic solvents, Transcutol® yielded the smallest liposomes, which ranged from 80 nm to 160 nm. Moreover, a more in-depth investigation showed that Transcutol® produced smaller or similar-sized particles under different temperature and lipid concentration conditions, compared with ethanol. Furthermore, we proved that particles zeta potential was not influenced by the organic solvent, production temperature, or lipid concentration. This work results show that Transcutol® could replace the conventional alcohol-based solvents and can potentially avoid filtration steps due to its low toxicity. Therefore, the present approach is appealing for DDS development.
KW - Continuous-flow synthesis
KW - Liposome nanoparticles
KW - Microfluidics
KW - Micromixers
KW - Organic solvents
KW - Transcutol®
UR - http://www.scopus.com/inward/record.url?scp=85096869932&partnerID=8YFLogxK
U2 - 10.1016/j.colsurfb.2020.111447
DO - 10.1016/j.colsurfb.2020.111447
M3 - Article
C2 - 33223347
AN - SCOPUS:85096869932
SN - 0927-7765
VL - 198
JO - Colloids and Surfaces B: Biointerfaces
JF - Colloids and Surfaces B: Biointerfaces
M1 - 111447
ER -